Healthy adults ( aged 19-40 years ) were randomized 1:1:1:1 to receive TIV or saline followed 4 months later by 2 doses , 3 weeks apart , of adjuvanted or nonadjuvanted A ( H1N1 ) pdm09 vaccine and followed up to study end ( day 507 ) .